Compositions and their uses directed to thymus and activation-regulated chemokine (TARC)
US7585968B2 · kind B2 · utility
4Cited by
11References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2006 |
| Grant date | Sep 8, 2009 |
| Priority date | — |
| Expiry date | Mar 27, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/346
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds, compositions and methods for modulating the expression of TARC in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders related to expression of TARC, airway hyperresponsiveness, and/or pulmonary inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.